Book Building
₹ - cr
₹ 0
-
₹ -
MumbaiNSE
-
-
-
Public issue of upto [*] equity shares of face value of Rs. 10 each (Equity Shares) of Intas Pharmaceuticals Limited (The company or The Issuer) for cash at a price of Rs. [*] per equity share including a share premium of Rs. [*] per equity share, aggregating up to Rs. [*] crores (The Issue) comprising of a fresh issue of upto equity shares by the company aggregating upto Rs. 225.00 crores (The Fresh Issue) and an offer for sale of 11,621,100 equity shares by Mozart Limited aggregating upto Rs. [*] crores (The Selling Shareholder) (The Offer for sale). The issue shall constitute [*]% of the post-issue paid up capital and [*]% of the fully diluted post-issue paid up capital of the company. The Face value of the equity share is Rs. 10 each.
Marketing authorization expenses. Setting up of research and development facility. General corporate purposes.
Intas Pharmaceuticals Ltd, C-13 Pannalal Silk, Mills Cmpd LBS Marg, Bhandup West, Mumbai - 400 078
Phone - 91-022-25963838
Fax - 91-022-25946969
Email - manoj_nair@intaspharma.com
Website - www.intaspharma.com